Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T00:42:52.863Z Has data issue: false hasContentIssue false

Direct Costs of a Contact Isolation Day: A Prospective Cost Analysis at a Swiss University Hospital

Published online by Cambridge University Press:  18 December 2017

Jan A. Roth
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland University of Basel, Basel, Switzerland
Claudia Hornung-Winter
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland University of Basel, Basel, Switzerland
Isabel Radicke
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland University of Basel, Basel, Switzerland
Balthasar L. Hug
Affiliation:
University of Basel, Basel, Switzerland Department of Internal Medicine, Kantonsspital Luzern, Lucerne, Switzerland
Monika Biedert
Affiliation:
University of Basel, Basel, Switzerland Department of Finance, University Hospital Basel, Basel, Switzerland.
Christian Abshagen
Affiliation:
University of Basel, Basel, Switzerland Department of Finance, University Hospital Basel, Basel, Switzerland.
Manuel Battegay
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland University of Basel, Basel, Switzerland
Andreas F. Widmer*
Affiliation:
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland University of Basel, Basel, Switzerland
*
Address correspondence to Prof Dr Andreas F. Widmer, MD, MS, Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland ([email protected]).

Abstract

We prospectively evaluated direct costs of contact precautions using on-site observation. Additional mean costs per patient day were calculated for extra materials used, increased workload, and one-off isolation activities. The cost of contact precautions was $158.90 (95% confidence interval, $124.90‒$192.80) per patient day.

Infect Control Hosp Epidemiol 2018;39:101–103

Type
Concise Communications
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10 Suppl 2):S65S164.Google Scholar
2. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(10 Suppl 2):S165S193.Google Scholar
3. Abad, C, Fearday, A, Safdar, N. Adverse effects of isolation in hospitalised patients: a systematic review. J Hosp Infect 2010;76:97102.Google Scholar
4. Cohen, CC, Cohen, B, Shang, J. Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect 2015;90:275284.CrossRefGoogle ScholarPubMed
5. Birgand, G, Moore, LS, Bourigault, C, et al. Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost? Clin Microbiol Infect 2016;22:162e1162e9.CrossRefGoogle ScholarPubMed
6. Verlee, K, Berriel-Cass, D, Buck, K, Nguyen, C. Cost of isolation: daily cost of isolation determined and cost avoidance demonstrated from the overuse of personal protective equipment in an acute care facility. Am J Infect Control 2014;42:448449.Google Scholar
7. Papia, G, Louie, M, Tralla, A, Johnson, C, Collins, V, Simor, AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective. Infect Control Hosp Epidemiol 1999;20:473477.Google Scholar
8. Hubner, C, Hubner, NO, Muhr, M, et al. Cost analysis of hospitalized Clostridium difficile-associated diarrhea (CDAD). GMS Hyg Infect Control 2015:10. Doc13.Google Scholar
Supplementary material: File

Roth et al. supplementary material

Tables S1 and S2

Download Roth et al. supplementary material(File)
File 30.8 KB